Your session is about to expire
← Back to Search
Other
EMS Group - Experimental for Healthy Subjects
N/A
Waitlist Available
Led By Amir Lerman, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 16
Awards & highlights
Study Summary
This trial is investigating the effects of whole-body EMS on various health outcomes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, week 16
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 16
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mean Change in Reactive Hyperemia Index (RHI)
Secondary outcome measures
Change in BMI
Change in Blood Glucose
Change in Creatinine Kinase (CK)
+11 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: EMS Group - ExperimentalExperimental Treatment1 Intervention
EMS device will be turned on during exercise for this group.
Group II: EMS Group - ControlPlacebo Group1 Intervention
EMS device will be turned off during exercise for this group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EMS Device On
2020
N/A
~80
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,207 Previous Clinical Trials
3,766,782 Total Patients Enrolled
Amir Lerman, MDPrincipal Investigator - Mayo Clinic
Mayo Clinic Hospital-Rochester Saint Marys Campus, Mayo Clinic Rochester
Technion-Israel Inst Of Tech (Medical School)
Mayo Grad School Med/Mayo Fndn (Residency)
18 Previous Clinical Trials
2,850 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger